Submitted by Anonymous (not verified) on 18 December 2025 - 11:15
Human medicines European public assessment report (EPAR): Caelyx pegylated liposomal, doxorubicin, Date of authorisation: 20/06/1996, Revision: 39, Status: Authorised
Source: